Regulation 1
Citation and commencement
These Regulations may be cited as the National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012 and shall come into operation on 1st September 2012.
/akn/sg/act/sub_leg/2007/NRDA-S410-2012
The full official text, structured for quick navigation. Copy any provision or jump straight to a section.
Quick answer
National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012 is Singapore Subsidiary Legislation, cited as Subsidiary Legislation NRDA-S410-2012 2007, currently marked in force and first recorded in 2007.
Citation and commencement
These Regulations may be cited as the National Registry of Diseases (Acute Myocardial Infarction Notification) Regulations 2012 and shall come into operation on 1st September 2012.
Definitions
In these Regulations, unless the context otherwise requires —“acute myocardial infarction” means myocardial infarction with one or more of the following:
changes in cardiac biomarkers beyond the typical limits applicable to the particular test used, together with —
symptoms indicative of myocardial ischaemia; or
electrocardiogram changes indicative of new myocardial ischaemia;
development of new pathological Q waves in the electrocardiogram of the patient; (c)new loss of viable myocardium or new regional wall motion abnormality;
fresh thrombus,and includes acute myocardial infarction developed as a complication of cardiovascular intervention for some other cardiac condition;“patient” means a person to whom a notification referred to in regulation 3 relates.
“acute myocardial infarction” means myocardial infarction with one or more of the following:
changes in cardiac biomarkers beyond the typical limits applicable to the particular test used, together with —
symptoms indicative of myocardial ischaemia; or
electrocardiogram changes indicative of new myocardial ischaemia;
development of new pathological Q waves in the electrocardiogram of the patient; (c)new loss of viable myocardium or new regional wall motion abnormality;
fresh thrombus,and includes acute myocardial infarction developed as a complication of cardiovascular intervention for some other cardiac condition;
“patient” means a person to whom a notification referred to in regulation 3 relates.
Form, time and manner of notification for acute myocardial infarction
For the purposes of section 6(1) of the Act, a notification by the manager of a healthcare institution to the Registrar that a person has been diagnosed with or is undergoing treatment for acute myocardial infarction at the healthcare institution shall —
contain the information specified in the First Schedule;
be made in the appropriate Form or Listing specified in the Second Schedule, which Form or Listing may be downloaded from the Registry’s Internet website at http://www.nrdo.gov.sg or obtained from the office of the Registry during such hours as the office is open for business;
be sent to the Registrar —
by hand (including by courier);
by registered mail; or
by using such secure electronic notification system as may be approved by the Registrar; and
be made —
where the patient has been diagnosed with acute myocardial infarction, not later than 3 months after the diagnosis of that disease was first made;
where the patient is undergoing treatment for acute myocardial infarction which commenced before 1st September 2012 and continues on or after that date, not later than 30th November 2012; or
where the patient is undergoing treatment for acute myocardial infarction which commenced on or after 1st September 2012, not later than 3 months after the treatment commenced.
Collection of additional information under section 7 of Act
Upon receiving a notification referred to in regulation 3 from the manager of a healthcare institution, the Registrar or an authorised Registry officer may, for the purposes of section 7(1) of the Act, require the manager to provide all or any of the additional information specified in the Third Schedule concerning the patient.